Summary
2021-2025 Japan Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
This new report contains 537 pages and 42 tables.
The report is available by section, and can be customized to specific information needs and budget.
The report presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including:
- Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.;
- Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others.;
- Test volume and sales forecasts for 40 cancer diagnostic procedures performed in Japanese hospitals. ;
- Current instrumentation technologies and feature comparison of leading analyzers.;
- Sales and market shares of & leading suppliers.;
- Emerging diagnostic technologies and their potential market applications.;
- Product development opportunities.;
- Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.;
- Business opportunities and strategic recommendations for supplier
Contains 537 pages and 42 tables
Companies Profiled
Competitive Assessments- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- GSK Biologicals
- Hologic
- Leica Biosystems
- Lonza
- Ortho-Clinical Diagnostics
- PerkinElmer
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens Healthineers
- Takara Bio
- Thermo Fisher
- WakoTable of contents
Methodology
Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.
Related Topics
Related Reports
-
2023 Global Drugs of Abuse Testing Market for 12 Assays--US, Europe, Japan--2022 Supplier Shares and 2022-2027 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
-
2023-2027 France Tumor Markers Testing Market
-
2023-2027 North America Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers
-
Global Orthopedic Medical Imaging Systems Industry
-
Global Angiography Devices Market 2023-2027
-
Medical Imaging Software Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
-
Global Medical Imaging Equipment Services Industry
-
2023-2027 Asia-Pacific Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor
-
Distribution Deals in Diagnostics 2016 to 2023
-
POCT Market in Europe 2023-2027
-
2023 Europe Drugs of Abuse Testing Market for 12 Assays--France, Germany, Italy, Spain, UK
-
Radioactive Tracer Market Size and Forecast to 2030 - Global Analysis by Tracer Type, Test Type, Application End User, and Geography
More Reports
-